Medizintechnik: Einstieg in einen Milliardenmarkt: Siemens Healthineers treibt Einsatz von Hirnimplantaten voran
Der Dax-Konzern arbeitet mit dem US-Unternehmen Paradromics zusammen, um den Einsatz von Gehirn-Computer-Schnittstellen als Therapie voranzubringen. Noch ist die Technologie im Forschungsstadium.
Frankfurt - The German medical technology company Siemens Healthineers has launched a strategic partnership with the Texas-based Neurotechnology firm Paradromics to advance the use of brain implants. According to early reports, the two companies will announce their joint initiative on Monday. Siemens Healthineers, a DAX-listed company and Paradromics, Neuralink's competitor, aim to develop a brain imaging platform for brain-computer interfaces (BCIs).
This platform will map the entire treatment process, from patient selection to assessment of the procedure. Matt Angle, Paradromics' founder and CEO, explained that a brain implant can only function if it's placed in the correct location. Since language, movement, or vision centers in the brain vary between individuals, precise placement of brain-computer interfaces is crucial for success.
BCIs connect the human brain directly to a computer or external device, bypassing nerves and muscles. This technology enables paralyzed individuals below the neck to control a robotic arm through thoughts.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
